Taysha Gene Therapies'Q1 Net Loss Widens
6 maj, 15:28
6 maj, 15:28
09:28 AM EDT, 05/06/2026 (MT Newswires) -- Taysha Gene Therapies (TSHA) reported a Q1 net loss Wednesday of $0.12 per diluted share, widening from a loss of $0.08 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.10.
The company didn't report revenue for the quarter ended March 31, compared with $2.3 million a year earlier.
Analysts surveyed by FactSet expected revenue of $800,000.
Shares of Taysha Gene Therapies were down 4% pre-bell.
6 maj, 15:28
09:28 AM EDT, 05/06/2026 (MT Newswires) -- Taysha Gene Therapies (TSHA) reported a Q1 net loss Wednesday of $0.12 per diluted share, widening from a loss of $0.08 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.10.
The company didn't report revenue for the quarter ended March 31, compared with $2.3 million a year earlier.
Analysts surveyed by FactSet expected revenue of $800,000.
Shares of Taysha Gene Therapies were down 4% pre-bell.
Analys
Aktierekommendationer
Inflationen
Intrum
Analys
Aktierekommendationer
Inflationen
Intrum
1 DAG %
Senast
OMX Stockholm 30
−0,60%
(vid stängning)
Aktier
Idag, 08:00
Våra svenskaste aktier
SpaceX
Igår, 14:32
Oljefonden redo att kliva in i Spacex
OMX Stockholm 30
1 DAG %
Senast
3 116,40